Trial
NCT02893332
Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Sichuan Provincial People's Hospital
Collaborators
—
Condition
Stage IV EGFR Mutated Non-Small Cell Lung Cancer
Intervention
Radiation: SBRT
Why stopped
After interim analysis, IRB recommend termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-03